The Molecular Pharmacology Program (MPP) links chemical synthesis an drug discovery with the biochemistry, structural biology, cell biology, and whole organism pharmacology of potential new drug candidates. Our membership includes faculty from the College of Science, College of Pharmacy, School of Medicine, and College of Engineering in order to provide the translational knowledge that can lead from drug discovery to drug development. Faculty expertise includes the areas of (i) synthesis and analysis of organic molecules, phosphoinositides, and nucleic acids, (ii) isolation of new anti- cancer leaders from natural sources, molecules, phosphoinositides, and nucleic acids, (ii) isolation of new anti- cancer leads from natural sources, (iii) protein engineering, folding, modification, and purification, (iv) photoaffinity labeling and active site mapping of proteins, (v) structural studies of proteins, nucleic acids and the small molecule complex using crystallography and NMR, (vi) polymer synthesis and modification of anti-cancer drugs of targeted delivery, (vii) studies of dosage forms, distribution, and mechanisms of toxicity and metabolism of anti-cancer drugs, (viii) mechanisms of radio-protection and sensitization, (ix) computational studies of complex systems, (x) receptor- mediated signal transduction and vesicular trafficking, and (xi) new methodologies for biomolecular interaction analysis and functional genomic screens.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Utah
Salt Lake City
United States
Zip Code
Polanco, Edward R; Western, Nicholas; Zangle, Thomas A (2018) Fabrication of Refractive-index-matched Devices for Biomedical Microfluidics. J Vis Exp :
Sorenson, Reed S; Deshotel, Malia J; Johnson, Katrina et al. (2018) Arabidopsis mRNA decay landscape arises from specialized RNA decay substrates, decapping-mediated feedback, and redundancy. Proc Natl Acad Sci U S A 115:E1485-E1494
Nevala-Plagemann, Christopher; Francis, Samual; Cavalieri, Courtney et al. (2018) Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy. ESMO Open 3:e000386
Camolotto, Soledad A; Pattabiraman, Shrivatsav; Mosbruger, Timothy L et al. (2018) FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer. Elife 7:
Wu, Yelena P; Nagelhout, Elizabeth; Aspinwall, Lisa G et al. (2018) A novel educational intervention targeting melanoma risk and prevention knowledge among children with a familial risk for melanoma. Patient Educ Couns 101:452-459
Li, Lian; Yang, Jiyuan; Wang, Jiawei et al. (2018) Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics. ACS Nano 12:3658-3670
Tiburcio, Patricia D B; Xiao, Bing; Chai, Yi et al. (2018) IDH1R132H is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment. Oncotarget 9:35100-35113
Ferris, Elliott; Abegglen, Lisa M; Schiffman, Joshua D et al. (2018) Accelerated Evolution in Distinctive Species Reveals Candidate Elements for Clinically Relevant Traits, Including Mutation and Cancer Resistance. Cell Rep 22:2742-2755
Liang, Wenjie; Yang, Pengfei; Huang, Rui et al. (2018) A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors. Clin Cancer Res :
Ou, Judy Y; Fowler, Brynn; Ding, Qian et al. (2018) A statewide investigation of geographic lung cancer incidence patterns and radon exposure in a low-smoking population. BMC Cancer 18:115

Showing the most recent 10 out of 1193 publications